Skip to main contentSkip to navigationSkip to search

Press release

Camurus’ Nomination Committee appointed for the Annual General Meeting 2020

15 October 2019 | Regulatory

Lund, Sweden — 15 October 2019 — Camurus today announced that the Nomination Committee for the Annual General Meeting, AGM, 2020 consists of the following persons, who together represent about 62 percent of the total number of shares and votes in Camurus based on the last known shareholder information:

  • Per Sandberg, appointed by Sandberg Development AB,
  • Max Mitteregger, appointed by Gladiator,
  • Arne Lööw, Fjärde AP-fonden, and
  • Per Olof Wallström, Chairman of the Board

The Nomination Committee’s proposals will be presented in the Notice to the AGM 2020 and on Camurus’ web site,

Shareholders who wish to submit proposals to the Nomination Committee are welcome to contact the Nomination Committee at the company’s address, Ideon Science Park, SE-223 70, Lund, Sweden. Proposals shall be submitted in due time before the Annual General Meeting, but not later than 6 February 2020, to ensure that the proposals can be adequately considered by the Nomination Committee.

The AGM 2020 in Camurus will be held on Thursday, 7 May 2020 at 5:00 pm CET in Lund. Shareholders who want to have a matter addressed at the AGM 2020 must submit such a proposal to the same address as above (subject “Annual General Meeting 2020”) by 25 March 2020 at the latest.

About Camurus
Camurus is a Swedish science-led biopharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of cancer, endocrine diseases, pain and addiction, which are developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX. For more information, visit

For more information
Per Olof Wallström, Chairman of the Board

Tel. +46 709 42 95 20

This information was submitted for publication at 7:00 am CET on 15 October 2019.

TypeError: Cannot read properties of undefined (reading 'url')